SAB Biotherapeutics CEO Eddie Sullivan says the genetically engineered cows have human antibodies. These special cows are injected with what essentially amounts to a coronavirus vaccine that will then cause them to try to fight off what the body sees as an infection — and they will produce a specifically targeted high-neutralizing antibody that can be used in patients. Sullivan says they hope to begin clinical trials later this summer.
Listen in the player above.